Literature DB >> 19204279

Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.

Julie Ann Edgeworth1, Graham S Jackson, Anthony R Clarke, Charles Weissmann, John Collinge.   

Abstract

Prions are comprised principally of aggregates of a misfolded host protein and cause fatal transmissible neurodegenerative disorders of humans and animals, such as variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Prions pose significant public health concerns, including contamination of blood products and surgical instruments; require laborious and often insensitive animal bioassay to detect; and resist conventional hospital sterilization methods. A major experimental advance was the cell culture-based scrapie cell assay, allowing prion titres to be estimated more precisely and an order of magnitude faster than by animal bioassays. Here we describe a bioassay method that exploits the marked binding affinity of prions to steel surfaces. Using steel wires as a concentrating and sensitization tool and combining with an adapted scrapie cell endpoint assay we can achieve, for mouse prions, a sensitivity 100x higher than that achieved in standard mouse bioassays. The rapidity and sensitivity of this assay offers a major advance over small animal bioassay in many aspects of prion research. In addition, its specific application in assay of metal-bound prions allows evaluation of novel prion decontamination methods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204279      PMCID: PMC2637901          DOI: 10.1073/pnas.0813342106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Inactivation of prions by physical and chemical means.

Authors:  D M Taylor
Journal:  J Hosp Infect       Date:  1999-12       Impact factor: 3.926

Review 2.  A general model of prion strains and their pathogenicity.

Authors:  John Collinge; Anthony R Clarke
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

3.  A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.

Authors:  J C Manson; E Jamieson; H Baybutt; N L Tuzi; R Barron; I McConnell; R Somerville; J Ironside; R Will; M S Sy; D W Melton; J Hope; C Bostock
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

4.  Species-barrier-independent prion replication in apparently resistant species.

Authors:  A F Hill; S Joiner; J Linehan; M Desbruslais; P L Lantos; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo.

Authors:  Rona M Barron; Susan L Campbell; Declan King; Anne Bellon; Karen E Chapman; R Anthony Williamson; Jean C Manson
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

6.  Prion strain discrimination in cell culture: the cell panel assay.

Authors:  Sukhvir P Mahal; Christopher A Baker; Cheryl A Demczyk; Emery W Smith; Christian Julius; Charles Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

7.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

Authors:  Stephen J Wroe; Suvankar Pal; Durrenajaf Siddique; Harpreet Hyare; Rebecca Macfarlane; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; Patricia Hewitt; John Collinge
Journal:  Lancet       Date:  2006-12-09       Impact factor: 79.321

8.  Kuru in the 21st century--an acquired human prion disease with very long incubation periods.

Authors:  John Collinge; Jerome Whitfield; Edward McKintosh; John Beck; Simon Mead; Dafydd J Thomas; Michael P Alpers
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

9.  Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation.

Authors:  Kurt Giles; David V Glidden; Robyn Beckwith; Rose Seoanes; David Peretz; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2008-11-14       Impact factor: 6.823

10.  Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.

Authors:  Sabrina Cronier; Nathalie Gros; M Howard Tattum; Graham S Jackson; Anthony R Clarke; John Collinge; Jonathan D F Wadsworth
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

View more
  23 in total

1.  Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.

Authors:  Sotirios Botsios; Sarah Tittman; Laura Manuelidis
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 2.  Harnessing prions as test agents for the development of broad-range disinfectants.

Authors:  Katja Wagenführ; Michael Beekes
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

Review 3.  Fate of prions in soil: a review.

Authors:  Christen B Smith; Clarissa J Booth; Joel A Pedersen
Journal:  J Environ Qual       Date:  2011 Mar-Apr       Impact factor: 2.751

4.  Spontaneous generation of mammalian prions.

Authors:  Julie A Edgeworth; Nathalie Gros; Jack Alden; Susan Joiner; Jonathan D F Wadsworth; Jackie Linehan; Sebastian Brandner; Graham S Jackson; Charles Weissmann; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

5.  Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.

Authors:  M Heather West Greenlee; Melissa Lind; Robyn Kokemuller; Najiba Mammadova; Naveen Kondru; Sireesha Manne; Jodi Smith; Anumantha Kanthasamy; Justin Greenlee
Journal:  Am J Pathol       Date:  2016-08-09       Impact factor: 4.307

6.  Fast and ultrasensitive method for quantitating prion infectivity titre.

Authors:  Natallia Makarava; Regina Savtchenko; Irina Alexeeva; Robert G Rohwer; Ilia V Baskakov
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

7.  A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay.

Authors:  Julie Ann Edgeworth; Anita Sicilia; Jackie Linehan; Sebastian Brandner; Graham S Jackson; John Collinge
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

8.  Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Authors:  Christina D Orrú; Jason M Wilham; Lynne D Raymond; Franziska Kuhn; Björn Schroeder; Alex J Raeber; Byron Caughey
Journal:  MBio       Date:  2011-05-10       Impact factor: 7.867

9.  Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.

Authors:  Graham S Jackson; Jesse Burk-Rafel; Julie Ann Edgeworth; Anita Sicilia; Sabah Abdilahi; Justine Korteweg; Jonathan Mackey; Claire Thomas; Guosu Wang; Jonathan M Schott; Catherine Mummery; Patrick F Chinnery; Simon Mead; John Collinge
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

10.  Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.

Authors:  Connie Luk; Samantha Jones; Claire Thomas; Nick C Fox; Tze H Mok; Simon Mead; John Collinge; Graham S Jackson
Journal:  JAMA Neurol       Date:  2016-12-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.